Comparative community outreach to increase cervical cancer screening in the Mississippi Delta

被引:79
作者
Castle, Philip E. [1 ,2 ]
Rausa, Alfio [3 ]
Walls, Tameka [4 ]
Gravitt, Patti E. [5 ]
Partridge, Edward E. [6 ]
Olivo, Vanessa [4 ]
Niwa, Shelley [4 ]
Morrissey, Kerry Grace [4 ]
Tucker, Laura [3 ]
Katki, Hormuzd [1 ]
Scarinci, Isabel [6 ,7 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA
[2] Amer Soc Clin Pathol Inst, Washington, DC USA
[3] Mississippi Dept Hlth, Jackson, MS USA
[4] Westat Corp, Rockville, MD USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[6] UAB Comprehens Canc Ctr, Birmingham, AL USA
[7] Univ Alabama Birmingham, Dept Prevent Med, Birmingham, AL USA
关键词
Pap; Cervical intraepithelial neoplasia (CIN); Cervical cancer; Human papillomavirus (HPV); Atypical squamous cells of undetermined significance (ASC-US); Hybrid Capture 2 (HC2); Health disparities; Cervical cancer screening; COLLECTED VAGINAL SAMPLES; HUMAN-PAPILLOMAVIRUS DNA; QUADRIVALENT VACCINE; WOMEN; SPECIMENS; FEASIBILITY; RISK;
D O I
10.1016/j.ypmed.2011.03.018
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. The aim of the study was to increase participation in cervical cancer screening of under-screened women living in the Mississippi Delta, a U.S. population at high risk for cervical cancer. Methods. We conducted a door-to-door feasibility study of women living in the Mississippi Delta to increase participation in cervical cancer screening in 2009-10. Women (n = 119) aged 26-65 years who had not been screened in last 3 years or more, were not pregnant, and had a cervix were offered a cost-free choice: clinic-based Pap testing or home self-collection with HPV DNA testing. Results. Seventy-seven women (64.7%) chose self-collection with HPV testing, of which sixty-two (80.5%) returned their self-collected specimen. By comparison, 42 women (35.3%) chose Pap testing, of which 17 (40.5%) attended their clinic appointment. Thus there was an almost 4-fold greater participation of under-mscreened women in self-collection with HPV testing than in free Pap testing (78.4% vs. 21.5%). Conclusions. We found that offering self-collection will increase participation in cervical cancer screening among under-screened populations living in the Mississippi Delta. Based on these preliminary results, we suggest that self-collection with HPV DNA testing might complement current Pap testing programs to reach under-screened populations of women, such as those living in the Mississippi Delta. Published by Elsevier Inc.
引用
收藏
页码:452 / 455
页数:4
相关论文
共 19 条
[1]  
[Anonymous], EXCESS CERVICAL CANC
[2]   Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study [J].
Belinson, J ;
Qiao, Y ;
Pretorius, R ;
Zhang, W ;
Keaton, K ;
Elson, P ;
Fischer, C ;
Lorincz, A ;
Zahniser, D ;
Wilbur, D ;
Pan, Q ;
Li, L ;
Biscotti, C ;
Dawson, A ;
Li, A ;
Wu, L ;
Ling, Y ;
Ma, CP ;
Yang, XP .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (05) :411-417
[3]   Shanxi Province cervical cancer screening study II: Self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology [J].
Belinson, JL ;
Qiao, YL ;
Pretorius, RG ;
Zhang, WH ;
Rong, SD ;
Huang, MN ;
Zhao, FH ;
Wu, LY ;
Ren, SD ;
Huang, RD ;
Washington, MF ;
Pan, QJ ;
Li, L ;
Fife, D .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (06) :819-826
[4]   Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens [J].
Castle, Philip E. ;
Sadorra, Mark ;
Garcia, Francisco A. R. ;
Cullen, Allison P. ;
Lorincz, Attila T. ;
Mitchell, Amy L. ;
Whitby, Denise ;
Chuke, Ronald ;
Kornegay, Janet R. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (04) :840-843
[5]   Detection of carcinogenic human papillomavirus in specimens collected with a novel self-sampling device [J].
Castle, Philip E. ;
Aftab, Asma ;
Saint-Jean, Gilbert ;
Mendez, Luis .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (06) :2158-2159
[6]   Five-Year Experience of Human Papillomavirus DNA and Papanicolaou Test Cotesting [J].
Castle, Philip E. ;
Fetterman, Barbara ;
Poitras, Nanty ;
Lorey, Yhomas ;
Shaber, Ruth ;
Kinney, Walter .
OBSTETRICS AND GYNECOLOGY, 2009, 113 (03) :595-600
[7]  
Centers for Disease Control and Prevention, 2010, MMWR-MORBID MORTAL W, V59, P1018
[8]   Patient navigation: A community based strategy to reduce cancer disparities [J].
Freeman, H .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2006, 83 (02) :139-141
[9]   Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases [J].
Garland, Suzanne M. ;
Hernandez-Avila, Mauricio ;
Wheeler, Cosette M. ;
Perez, Gonzalo ;
Harper, Diane M. ;
Leodolter, Sepp ;
Tang, Grace W. K. ;
Ferris, Daron G. ;
Steben, Marc ;
Bryan, Janine ;
Taddeo, Frank J. ;
Railkar, Radha ;
Esser, Mark T. ;
Sings, Heather L. ;
Nelson, Micki ;
Boslego, John ;
Sattler, Carlos ;
Barr, Eliav ;
Koutsky, Laura A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) :1928-1943
[10]   HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study [J].
Gok, Murat ;
Heideman, Danielle A. M. ;
van Kemenade, Folkert J. ;
Berkhof, Johannes ;
Rozendaal, Lawrence ;
Spruyt, Johan W. M. ;
Voorhorst, Feja ;
Belien, Jeroen A. M. ;
Babovic, Milena ;
Snijders, Peter J. F. ;
Meijer, Chris J. L. M. .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 :905